128 results on '"Cheville, John C"'
Search Results
2. Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2/pT3 HPV-negative penile squamous cell carcinoma
3. Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study
4. Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma
5. Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic disease
6. Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma
7. An update on computational pathology tools for genitourinary pathology practice: A review paper from the Genitourinary Pathology Society (GUPS)
8. Circulating antigen-primed cytotoxic T-cells in patients with renal tumors treated with surgery
9. Deepfake Histologic Images for Enhancing Digital Pathology
10. Incidence and predictors of ipsilateral local recurrence following partial nephrectomy
11. Progression of Chronic Kidney Disease Following Radical and Partial Nephrectomy
12. Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors
13. Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features
14. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology
15. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
16. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
17. Next generation sequencing-based identification of fusion-driven renal neoplasia: A single institution experience
18. Diagnostic pitfalls: Florid mesothelial hyperplasia and mesothelioma of the tunica vaginalis
19. JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management
20. Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
21. Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma
22. The Association of Aspirin Use with Survival Following Radical Cystectomy
23. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis
24. Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3 + 4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance
25. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management
26. Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent
27. Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer
28. Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
29. Complex immunophenotypes: renal cell carcinoma with concurrent loss of SDHB/INI1 and FH/INI1
30. Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer
31. Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Detected by 11C-Choline Positron Emission Tomography/Computerized Tomography
32. Diabetes Mellitus is Independently Associated with an Increased Risk of Mortality in Patients with Clear Cell Renal Cell Carcinoma
33. Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome
34. Prostate Cancer Ki-67 (MIB-1) Expression, Perineural Invasion, and Gleason Score as Biopsy-Based Predictors of Prostate Cancer Mortality: The Mayo Model
35. Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors
36. ALK-rearranged renal cell carcinoma with nuclear mitotic apparatus protein 1 (NUMA1) as a fusion partner
37. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients
38. Prognostic Significance of Measured Depth of Invasion of Urothelial Carcinoma of the Bladder Compared to the 2010 American Joint Committee on Cancer pT2 and pT3 Classifications
39. Does Partial Cystectomy Compromise Oncologic Outcomes for Patients with Bladder Cancer Compared to Radical Cystectomy? A Matched Case-Control Analysis
40. The Impact of Squamous and Glandular Differentiation on Survival After Radical Cystectomy for Urothelial Carcinoma
41. Shared Gene Expression Alterations in Prostate Cancer and Histologically Benign Prostate from Patients with Prostate Cancer
42. Expression of endothelin 2 and localized clear cell renal cell carcinoma
43. Clinical and Pathological Features Associated With Prognosis in Patients With Papillary Renal Cell Carcinoma
44. Outcomes and Clinicopathologic Variables Associated With Late Recurrence After Nephrectomy for Localized Renal Cell Carcinoma
45. Detection of Asymptomatic Recurrence During Routine Oncological Followup After Radical Cystectomy is Associated With Improved Patient Survival
46. Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carcinoma: Results From a Large, Single Institution Cohort
47. Molecular alterations in primary and metastatic PEComa: insights from the AACR project GENIE data set
48. Unclassified Renal Cell Carcinoma: Impact on Survival Following Nephrectomy
49. Isochromosome 12p and polysomy 12 in primary central nervous system germ cell tumors: frequency and association with clinicopathologic features
50. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.